Cargando…
Mechanistic Understanding of the Palmitoylation of G(o) Protein in the Allosteric Regulation of Adhesion Receptor GPR97
Adhesion G-protein-coupled receptors (aGPCRs)—a major family of GPCRs—play critical roles in the regulation of tissue development and cancer progression. The orphan receptor GPR97, activated by glucocorticoid stress hormones, is a prototypical aGPCR. Although it has been established that the palmito...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504338/ https://www.ncbi.nlm.nih.gov/pubmed/36145604 http://dx.doi.org/10.3390/pharmaceutics14091856 |
Sumario: | Adhesion G-protein-coupled receptors (aGPCRs)—a major family of GPCRs—play critical roles in the regulation of tissue development and cancer progression. The orphan receptor GPR97, activated by glucocorticoid stress hormones, is a prototypical aGPCR. Although it has been established that the palmitoylation of the C-terminal G(o) protein is essential for G(o)’s efficient engagement with the active GPR97, the detailed allosteric mechanism remains to be clarified. Hence, we performed extensive large-scale molecular dynamics (MD) simulations of the GPR97−G(o) complex in the presence or absence of G(o) palmitoylation. The conformational landscapes analyzed by Markov state models revealed that the overall conformation of GPR97 is preferred to be fully active when interacting with palmitoylated G(o) protein. Structural and energetic analyses indicated that the palmitoylation of G(o) can allosterically stabilize the critical residues in the ligand-binding pocket of GPR97 and increase the affinity of the ligand for GPR97. Furthermore, the community network analysis suggests that the palmitoylation of G(o) not only allosterically strengthens the internal interactions between G(αo) and G(βγ), but also enhances the coupling between G(o) and GPR97. Our study provides mechanistic insights into the regulation of aGPCRs via post-translational modifications of the G(o) protein, and offers guidance for future drug design of aGPCRs. |
---|